Shan Lu, PhD
Shan Lu, MD, PhD, serves as Director of the Laboratory of Nucleic Acid Vaccines at the University of Massachusetts Medical School and is Professor Emeritus at the UMass Chan Medical School, where his focus is the immunogenicity of protein antigens. Dr. Lu was an early pioneer in nucleic acid vaccines (DNA and RNA) in the early 1990s; he developed the world’s first polyvalent DNA/protein HIV vaccine into human clinical studies. Dr. Lu has published more than 200 papers in leading scientific journals and co-authored more than 10 specialty books. He served as president of the International Society for Vaccines and co-chair of its board of directors. Dr. Lu is the founding Editor-in-Chief of Emerging Microbes and Infections, a leading journal on infectious diseases.